Management Strategies for Mycobacterium Avium Complex Infections: Diagnosis and Treatment of a Growing Health Threat (Webcourse)

The incidence of nontuberculous mycobacterial infections caused by Mycobacterium avium complex (NTM-MAC) have increased dramatically in recent decades, while the 5-year survival of patients with NTM-MAC infections remains similar to that of patients with lung cancer. Diagnoses are often delayed due to the nonspecific presentation of NTM-MAC and radiological findings that overlap with other pulmonary diseases. NTM-MAC treatment is also difficult with the use of multiple antibiotic regimens and frequency of refractory disease. In recent years, the availability of amikacin liposome inhalation suspension (ALIS) has provided another option for patients with NTM-MAC who do not achieve a negative sputum culture after a minimum of six consecutive months of a multidrug regimen therapy.

This activity, “Management Strategies for Mycobacterium Avium Complex Infections: Diagnosis and Treatment of a Growing Health Threat” will provide pulmonologists with expert-led discussions of guideline-based diagnosis and treatment of NTM to improve clinician skill in identifying early clinical signs of NTM-MAC, diagnosis, treatment selection, and effective communication with patients regarding NTM-MAC management

Jointly provided by the Potomac Center for Medical Education and Rockpointe

Patient resources provided by:

This activity is supported by an Educational Grant from Insmed.